No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy ; volume:12 ; number:4 ; day:8 ; month:6 ; year:2023 ; pages:2199-2208 ; date:8.2023
Ophthalmology and therapy ; 12, Heft 4 (8.6.2023), 2199-2208, 8.2023
- Urheber
-
Servillo, Andrea
Sacconi, Riccardo
Zucchiatti, Ilaria
Grachova, Elena
Querques, Lea
Prascina, Francesco
Tombolini, Beatrice
Dorin, Giorgio
Mainster, Martin
Bandello, Francesco
Querques, Giuseppe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-023-00739-4
- URN
-
urn:nbn:de:101:1-2023092508320569263459
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Servillo, Andrea
- Sacconi, Riccardo
- Zucchiatti, Ilaria
- Grachova, Elena
- Querques, Lea
- Prascina, Francesco
- Tombolini, Beatrice
- Dorin, Giorgio
- Mainster, Martin
- Bandello, Francesco
- Querques, Giuseppe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy
Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathy
Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy
Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy
Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathy
Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy
Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy
Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathy
Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy